Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hafner

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|August 1, 1991
From the National Institutes of Health. Summary of the workshop on future directions in discovery and development of therapeutic agents for opportunistic infections associated with AIDSB E Laughon, H S Allaudeen, J M Becker, et al.
Annals of Internal Medicine|April 15, 1993
Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndromeJ Wheat, R Hafner, M Wulfsohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 1999
A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)W M El-Sadr, R Luskin-Hawk, T M Yurik, et al.
AIDS (London, England)|August 16, 2001
A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /lS L Koletar, A E Heald, D Finkelstein, et al.
The New England Journal of Medicine|July 31, 1997
A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDSF M Gordin, J P Matts, C Miller, et al.
JAMA|March 25, 2000
Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study GroupF Gordin, R E Chaisson, J P Matts, et al.
AIDS (London, England)|October 28, 1997
Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinical Trials Group 222 Protocol TeamD C Perlman, W M El Sadr, L B Heifets, et al.
AIDS (London, England)|January 6, 1999
A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study TeamD M Parenti, P L Williams, R Hafner, et al.
The New England Journal of Medicine|December 24, 1998
Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials GroupW M El-Sadr, R L Murphy, T M Yurik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 1999
A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study GroupM S Saag, G A Cloud, J R Graybill, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|August 1, 1991
From the National Institutes of Health. Summary of the workshop on future directions in discovery and development of therapeutic agents for opportunistic infections associated with AIDSB E Laughon, H S Allaudeen, J M Becker, et al.
Annals of Internal Medicine|April 15, 1993
Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndromeJ Wheat, R Hafner, M Wulfsohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 1999
A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)W M El-Sadr, R Luskin-Hawk, T M Yurik, et al.
AIDS (London, England)|August 16, 2001
A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /lS L Koletar, A E Heald, D Finkelstein, et al.
The New England Journal of Medicine|July 31, 1997
A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDSF M Gordin, J P Matts, C Miller, et al.
JAMA|March 25, 2000
Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study GroupF Gordin, R E Chaisson, J P Matts, et al.
AIDS (London, England)|October 28, 1997
Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinical Trials Group 222 Protocol TeamD C Perlman, W M El Sadr, L B Heifets, et al.
AIDS (London, England)|January 6, 1999
A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study TeamD M Parenti, P L Williams, R Hafner, et al.
The New England Journal of Medicine|December 24, 1998
Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials GroupW M El-Sadr, R L Murphy, T M Yurik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 1999
A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study GroupM S Saag, G A Cloud, J R Graybill, et al.
Pageof 8